Orphan designation: setanaxib Treatment of primary biliary cholangitis, 06/01/2021 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 21 August 2026 - 13:52

Orphan designation: setanaxib Treatment of primary biliary cholangitis, 06/01/2021 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-20-2387

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters